Meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage IA non-small-cell lung cancer in the eighth edition TNM classification

References

• Suzuki K, Kusumoto M, Watanabe S, Tsuchiya R, Asamura H. Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann Thorac Surg. 2006;81(2):413–419. doi:10.1016/j.athoracsur.2005.07.05816427823
   PubMed Web of Science ®Google Scholar
• Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K. Neither maximum tumor size nor solid component size is prognostic in part-solid lung cancer: impact of tumor size should be applied exclusively to solid lung cancer. Ann Thorac Surg. 2016;102(2):407–415. doi:10.1016/j.athoracsur.2016.02.07427177840
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Suzuki K, Takamochi K, Oh S. What is the radiological definition of part-solid tumour in lung cancer ? Dagger. Eur J Cardiothorac Surg. 2017;51(2):242–247. doi:10.1093/ejcts/ezw34428119328
   PubMed Web of Science ®Google Scholar
• Tsutani Y, Miyata Y, Yamanaka T, et al. Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: prognostic comparison using high-resolution computed tomography findings. J Thorac Cardiovasc Surg. 2013;146(1):17–23. doi:10.1016/j.jtcvs.2012.11.01923246051
   PubMed Web of Science ®Google Scholar
• Tsutani Y, Miyata Y, Nakayama H, et al. Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors with T1 lung adenocarcinoma. Ann Oncol. 2013;24(9):2376–2381. doi:10.1093/annonc/mdt23023788749
   PubMed Web of Science ®Google Scholar
• Tsutani Y, Miyata Y, Nakayama H, et al. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study. J Thorac Cardiovasc Surg. 2012;143(3):607–612. doi:10.1016/j.jtcvs.2011.10.03722104678
   PubMed Web of Science ®Google Scholar
• Hattori A, Matsunaga T, Hayashi T, Takamochi K, Oh S, Suzuki K. Prognostic impact of the findings on thin-section computed tomography in patients with subcentimeter non-small cell lung cancer. J Thorac Oncol. 2017;12(6):954–962. doi:10.1016/j.jtho.2017.02.01528257958
   PubMed Web of Science ®Google Scholar
• Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K. Importance of ground glass opacity component in clinical stage IA radiologic invasive lung cancer. Ann Thorac Surg. 2017;104(1):313–320. doi:10.1016/j.athoracsur.2017.01.07628433219
   PubMed Web of Science ®Google Scholar
• Hwang EJ, Park CM, Ryu Y, et al. Pulmonary adenocarcinomas appearing as part-solid ground-glass nodules: is measuring solid component size a better prognostic indicator ? Eur Radiol. 2015;25(2):558–567. doi:10.1007/s00330-014-3441-125274618
   PubMed Web of Science ®Google Scholar
• Su H, Dai C, She Y, et al. Which T descriptor is more predictive of recurrence after sublobar resection: whole tumour size versus solid component size ? Eur J Cardiothorac Surg. 2018;54:1028–1036. doi:10.1093/ejcts/ezy22529901712
   PubMed Web of Science ®Google Scholar
• Berry MF, Gao R, Kunder CA, et al. Presence of even a small ground-glass component in lung adenocarcinoma predicts better survival. Clin Lung Cancer. 2018;19(1):e47–e51. doi:10.1016/j.cllc.2017.06.02028743420
   PubMed Web of Science ®Google Scholar
• Lee KH, Goo JM, Park SJ, et al. Correlation between the size of the solid component on thin-section CT and the invasive component on pathology in small lung adenocarcinomas manifesting as ground-glass nodules. J Thorac Oncol. 2014;9(1):74–82. doi:10.1097/JTO.000000000000001924346095
   PubMed Web of Science ®Google Scholar
• Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K. Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2017;154(6):2102–2110. e2101. doi:10.1016/j.jtcvs.2017.08.03728947198
   PubMed Web of Science ®Google Scholar
• Chansky K, Detterbeck FC, Nicholson AG, et al. The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer. J Thorac Oncol. 2017;12(7):1109–1121. doi:10.1016/j.jtho.2017.04.01128461257
   PubMed Web of Science ®Google Scholar
• Rami-Porta R, Asamura H, Travis WD, Rusch VW. Lung cancer – major changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):138–155. doi:10.3322/caac.2139028140453
   PubMed Web of Science ®Google Scholar
• Hwang EJ, Park CM, Kim YT, Kim H, Goo JM. Microscopic invasions, prognoses, and recurrence patterns of stage I adenocarcinomas manifesting as part-solid ground-glass nodules: comparison with adenocarcinomas appearing as solid nodules after matching their solid parts’ size. Medicine. 2016;95(15):e3419. doi:10.1097/MD.000000000000486427082622
   PubMed Web of Science ®Google Scholar
• Takenaka T, Yamazaki K, Miura N, Takeo S. Prognostic ability of new T1 descriptors in the tumour, node and metastasis classification of surgically treated non-small-cell lung cancer. Interact Cardiovasc Thorac Surg. 2018;27:714–719. doi:10.1093/icvts/ivy16429788086
   PubMed Web of Science ®Google Scholar
• Shin KW, Cho S, Chung JH, et al. Comparison of prognosis of solid and part-solid node-negative adenocarcinoma with the same invasive component size. Ann Thorac Surg. 2017;103(5):1654–1660. doi:10.1016/j.athoracsur.2016.10.04028131430
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Reprint–preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther. 2009;89(9):873–880. 19723669
   PubMed Web of Science ®Google Scholar
• Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. doi:10.1186/1745-6215-8-1617555582
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi:10.1136/bmj.327.7414.55712958120
   PubMed Web of Science ®Google Scholar
• Travis WD, Asamura H, Bankier AA, et al. The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol. 2016;11(8):1204–1223. doi:10.1016/j.jtho.2016.03.02527107787
   PubMed Web of Science ®Google Scholar
• Yamanashi K, Okumura N, Yamamoto Y, Takahashi A, Nakashima T, Matsuoka T. Comparing part-solid and pure-solid tumors in the TNM classification of lung cancer (eighth edition). Thorac Cardiovasc Surg. Epub 2018 May 29.
   Web of Science ®Google Scholar
• Nakayama H, Okumura S, Daisaki H, et al. Value of integrated positron emission tomography revised using a phantom study to evaluate malignancy grade of lung adenocarcinoma: a multicenter study. Cancer. 2010;116(13):3170–3177. doi:10.1002/cncr.2524420564630
   PubMed Web of Science ®Google Scholar
• Okada M, Nakayama H, Okumura S, et al. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma. J Thorac Cardiovasc Surg. 2011;141(6):1384–1391. doi:10.1016/j.jtcvs.2011.02.00721440264
   PubMed Web of Science ®Google Scholar
• Sica G, Yoshizawa A, Sima CS, et al. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol. 2010;34(8):1155–1162. doi:10.1097/PAS.0b013e3181e4ee3220551825
   PubMed Web of Science ®Google Scholar
• Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K. Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma. Eur J Cardiothorac Surg. 2017;51(3):518–525. doi:10.1093/ejcts/ezw33628082475
   PubMed Web of Science ®Google Scholar
• Fukui T, Taniguchi T, Kawaguchi K, et al. Comparisons of the clinicopathological features and survival outcomes between lung cancer patients with adenocarcinoma and squamous cell carcinoma. Gen Thorac Cardiovasc Surg. 2015;63(9):507–513. doi:10.1007/s11748-015-0564-526022944
   PubMedGoogle Scholar
• Kawase A, Yoshida J, Ishii G, et al. Differences between squamous cell carcinoma and adenocarcinoma of the lung: are adenocarcinoma and squamous cell carcinoma prognostically equal ? Jpn J Clin Oncol. 2012;42(3):189–195. doi:10.1093/jjco/hyr18822210923
   PubMed Web of Science ®Google Scholar
• Ginsberg RJ, Rubinstein LV; Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60(3):615–622. discussion 622–613. 7677489
   PubMed Web of Science ®Google Scholar
• Nakamura K, Saji H, Nakajima R, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol. 2010;40(3):271–274. doi:10.1093/jjco/hyp15619933688
   PubMed Web of Science ®Google Scholar
• Suzuki K, Koike T, Asakawa T, et al. A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol. 2011;6(4):751–756. doi:10.1097/JTO.0b013e31821038ab21325976
   PubMed Web of Science ®Google Scholar
• Asamura H, Hishida T, Suzuki K, et al. Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. J Thorac Cardiovasc Surg. 2013;146(1):24–30. doi:10.1016/j.jtcvs.2012.12.04723398645
   PubMed Web of Science ®Google Scholar